Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
HTH
|
Gerald J Ford |
BUY
Bona fide gift
|
Indirect | 1,972 Added 2.8% |
-
|
Dec 31
2020 |
MDVL
|
Abg Wtt Med Avail LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 12,670 Added 0.19% |
$190,050
$15.0 p/Share
|
Dec 31
2020 |
SF
|
Ronald J Kruszewski
Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 43,413 Added 3.24% |
-
|
Dec 31
2020 |
SF
|
Ronald J Kruszewski
Chief Executive Officer |
SELL
Bona fide gift
|
Direct | 6,492 Reduced 0.52% |
-
|
Dec 31
2020 |
SF
|
Ronald J Kruszewski
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 19,428 Reduced 1.5% |
$980,337
$50.46 p/Share
|
Dec 31
2020 |
SF
|
James M Marischen
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,324 Added 6.44% |
-
|
Dec 31
2020 |
SF
|
James M Marischen
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,040 Reduced 3.2% |
$52,478
$50.46 p/Share
|
Dec 31
2020 |
SF
|
James M Zemlyak
Co-President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,292 Reduced 0.1% |
$65,194
$50.46 p/Share
|
Dec 31
2020 |
SF
|
James M Zemlyak
Co-President |
BUY
Exercise of conversion of derivative security
|
Direct | 2,887 Added 0.23% |
-
|
Dec 31
2020 |
EXC
|
Nicholas Debenedictis
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 941 Added 1.64% |
$38,769
$41.2 p/Share
|
Dec 31
2020 |
NTRS
|
Dean M Harrison
Director |
BUY
Grant, award, or other acquisition
|
Direct | 402 Added 2.87% |
$37,442
$93.14 p/Share
|
Dec 31
2020 |
NTRS
|
Becerra Jose Luis Prado
Director |
BUY
Grant, award, or other acquisition
|
Direct | 295 Added 1.84% |
$27,476
$93.14 p/Share
|
Dec 31
2020 |
NTRS
|
Thomas E Richards
Director |
BUY
Grant, award, or other acquisition
|
Direct | 375 Added 2.99% |
$34,927
$93.14 p/Share
|
Dec 31
2020 |
NTRS
|
Donald Thompson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 402 Added 3.3% |
$37,442
$93.14 p/Share
|
Dec 31
2020 |
NTRS
|
Charles A Tribbett
Director |
BUY
Grant, award, or other acquisition
|
Direct | 295 Added 1.06% |
$27,476
$93.14 p/Share
|
Dec 31
2020 |
DVCR
|
Osmium Partners, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,778 Added 2.98% |
$55,269
$2.66 p/Share
|
Dec 31
2020 |
FRME
|
Michael J Stewart
President |
BUY
Grant, award, or other acquisition
|
Direct | 40 Added 0.06% |
$1,056
$26.39 p/Share
|
Dec 31
2020 |
FRME
|
Jeffrey B Lorentson
Chief Audit Executive |
BUY
Grant, award, or other acquisition
|
Direct | 13 Added 0.1% |
$343
$26.39 p/Share
|
Dec 31
2020 |
FRME
|
William L Hoy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 396 Added 1.33% |
$14,814
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Clark C Kellogg Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 396 Added 10.73% |
$14,814
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Patrick A Sherman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 417 Added 0.88% |
$15,600
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Michael R Becher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 459 Added 3.0% |
$17,171
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Jean L Wojtowicz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 459 Added 1.25% |
$17,171
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
H Douglas Chaffin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 417 Added 1.13% |
$15,600
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Michael C Marhenke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 396 Added 1.09% |
$14,814
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Gary Lehman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 396 Added 0.93% |
$14,814
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Michael J Fisher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 396 Added 7.4% |
$14,814
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Charles E Schalliol
Director |
BUY
Grant, award, or other acquisition
|
Direct | 605 Added 1.22% |
$22,633
$37.41 p/Share
|
Dec 31
2020 |
FRME
|
Howard Halderman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 448 Added 3.14% |
$16,760
$37.41 p/Share
|
Dec 31
2020 |
INTU
|
Sasan K Goodarzi
CEO, President and Director |
SELL
Payment of exercise price or tax liability
|
Direct | 434 Reduced 0.47% |
$164,855
$379.85 p/Share
|
Dec 31
2020 |
INTU
|
Sasan K Goodarzi
CEO, President and Director |
BUY
Exercise of conversion of derivative security
|
Direct | 834 Added 0.89% |
-
|
Dec 31
2020 |
INTU
|
Brad D Smith
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 2,649 Reduced 0.73% |
$1,006,223
$379.85 p/Share
|
Dec 31
2020 |
INTU
|
Brad D Smith
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,448 Added 1.48% |
-
|
Dec 31
2020 |
QCOM
|
Mark Fields
Director |
BUY
Grant, award, or other acquisition
|
Direct | 188 Added 5.78% |
-
|
Dec 31
2020 |
QCOM
|
Mark D Mclaughlin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 451 Added 5.31% |
-
|
Dec 31
2020 |
QCOM
|
Jamie S Miller
Director |
BUY
Grant, award, or other acquisition
|
Direct | 94 Added 30.32% |
-
|
Dec 31
2020 |
QCOM
|
Neil Smit
Director |
BUY
Grant, award, or other acquisition
|
Direct | 188 Added 6.35% |
-
|
Dec 31
2020 |
T
|
David S. Huntley
SEVP&Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 379 Added 2.34% |
$10,900
$28.76 p/Share
|
Dec 31
2020 |
T
|
Lori M Lee
Global Mktg Ofr & SEVP HR&Intl |
BUY
Grant, award, or other acquisition
|
Indirect | 260 Added 3.44% |
$7,478
$28.76 p/Share
|
Dec 31
2020 |
T
|
David R Mc Atee Ii
Sr. Exec. VP and Gen. Counsel |
BUY
Grant, award, or other acquisition
|
Indirect | 1,536 Added 1.92% |
$44,175
$28.76 p/Share
|
Dec 31
2020 |
T
|
Jeffery S. Mc Elfresh
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 709 Added 1.65% |
$20,391
$28.76 p/Share
|
Dec 31
2020 |
T
|
Angela Santone
Sr. Exec VP-Human Resources |
BUY
Grant, award, or other acquisition
|
Indirect | 312 Added 8.82% |
$8,973
$28.76 p/Share
|
Dec 31
2020 |
T
|
John Joseph Stephens
Sr. Exec. VP and CFO |
BUY
Grant, award, or other acquisition
|
Indirect | 1,359 Added 0.52% |
$39,085
$28.76 p/Share
|
Dec 31
2020 |
BMY
|
Nadim Ahmed
EVP and President, Hematology |
SELL
Payment of exercise price or tax liability
|
Direct | 7,660 Reduced 16.46% |
$475,150
$62.03 p/Share
|
Dec 31
2020 |
BMY
|
Nadim Ahmed
EVP and President, Hematology |
BUY
Exercise of conversion of derivative security
|
Direct | 14,946 Added 24.3% |
-
|
Dec 31
2020 |
BMY
|
David V Elkins
EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 11,931 Reduced 15.08% |
$740,080
$62.03 p/Share
|
Dec 31
2020 |
BMY
|
David V Elkins
EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 20,624 Added 20.68% |
-
|
Dec 31
2020 |
BMY
|
Rupert Vessey
EVP & President, Research |
SELL
Payment of exercise price or tax liability
|
Direct | 13,257 Reduced 19.47% |
$822,332
$62.03 p/Share
|
Dec 31
2020 |
BMY
|
Rupert Vessey
EVP & President, Research |
BUY
Exercise of conversion of derivative security
|
Direct | 25,866 Added 27.53% |
-
|
Dec 31
2020 |
DIS
|
Safra Catz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 483 Added 5.99% |
$84,820
$175.61 p/Share
|
Dec 31
2020 |